10-K
File 001-38295
10-K
- Filing date
- 17 Mar 2026
- Reporting date
- 31 Dec 2025
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
X4 Pharmaceuticals, Inc reports
- Company location
- Boston, MA
- Fiscal year end
- 31 December
Company
Names, identifiers, and filing context for this profile.
1 identity field
SEC filing record 1 source field available
X4 Pharmaceuticals, Inc has filed 796 SEC EDGAR filings since 24 Sep 2010
SEC filing history
Showing 1-9 of 9 matching filings.
Per page
25
Current page
1
10-K
File 001-38295
10-K
- Filing date
- 26 Mar 2025
- Reporting date
- 31 Dec 2024
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
10-K
File 001-38295
10-K
- Filing date
- 21 Mar 2024
- Reporting date
- 31 Dec 2023
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
10-K
File 001-38295
10-K
- Filing date
- 21 Mar 2023
- Reporting date
- 31 Dec 2022
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
10-K
File 001-38295
10-K
- Filing date
- 17 Mar 2022
- Reporting date
- 31 Dec 2021
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
10-K
File 001-38295
10-K
- Filing date
- 19 Mar 2021
- Reporting date
- 31 Dec 2020
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
10-K
File 001-38295
10-K
- Filing date
- 12 Mar 2020
- Reporting date
- 31 Dec 2019
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
10-K
File 001-38295
10-K
- Filing date
- 11 Mar 2019
- Reporting date
- 31 Dec 2018
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
10-K
File 001-38295
10-K
- Filing date
- 09 Mar 2018
- Reporting date
- 31 Dec 2017
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing